ÂÜÀòÂÒÂ×

Ms. Burleson has more than 20 years of progressive experience in advising and developing key business support operations across a variety of industries, including healthcare, pharmaceutical, and biomedical R&D. Ms. Burleson is the Chief Operating Officer of Translational Genomics Research Institute and the President of TGen Health Ventures. Previously, Ms. Burleson served as Chief Financial Officer at Lovelace Medical Foundation, President at Lovelace Scientific Resources, and as Senior Associate of Tax, Audit, and Advisory Services at KPMG.

Ms. Burleson earned a B.B.A. in Accounting and a Master of Business Administration from the University of New Mexico.